trial · primary record
Metreleptin
Lipodystrophy
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 24 |
| Primary completion | 2027-07-31 |
| Primary endpoint | Serum triglycerides |
| Registry ID | NCT02262832 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:05.746Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02262832
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.